More than 70 different genes have been identified to cause the various forms of CMT. For the demyelinating forms of CMT, a genetic cause can be found most of the time, with CMT1A (PMP22 duplication) explaining ~70% of these cases. In contrast, a mutation in one of the currently known genes can be found in less than 40% of axonal (CMT2) cases, mostly for the severe, early onset cases. Genetic studies have fundamentally transformed our knowledge on CMT and have catalyzed much of the research in neuropathies in the past 20 years. We fully expect that by taking advantage of new technologies, this progress will continue to a point where (1) >90% of CMT1 and CMT2 patients can receive a genetic diagnosis;(2) a sizable number of important genetic modifiers that account for a significant portion of the phenotypic variability in some forms of CMT will be identified;(3) a proportion of the heretofore idiopathic/sporadic neuropathies will be found to have a genetic cause;(4) genetic risk factors for developing neuropathy to diabetes and various medications will be identified. The members of the INC consortium work in a collaborative manner with multiple sources of funding to achieve these goals. In particular, the INC has allowed us to collect high-quality samples for reliable gene modifier studies, as demonstrated by our results on a CMT1A study. In this renewal, we propose to expand our efforts to find new genes that cause CMT and genetic modifiers of CMT. These modifiers will be important targets for intervention, and may well be important in the manifestations of acquired peripheral neuropathies, and even other diseases, such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis, in which axonal degeneration has been implicated in the pathogenesis. Finally, as our collaborative group and others move rapidly towards genomic approaches, we will establish a unified, secure, and accessible resource for all genomic data of the INC that will be open to all CMT researchers, that can also serve as a blueprint for other RDCRN groups interested in inherited diseases.

Public Health Relevance

Clinical Research Project 2 provides the mechanism to identify novel genetic causes of CMT and identify modifier genes that alter the natural history of CMT, both of which are among the most important goals of the INC. Achieving these goals requires large numbers of well characterized patients with common and rare forms of inherited neuropathies that can only be obtained through an international consortium of expert investigators and experts in Next Generation Sequencing such as exist in the INC.

Agency
National Institute of Health (NIH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
2U54NS065712-07
Application #
8918127
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Gwinn, Katrina
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Dortch, Richard D; Dethrage, Lindsey M; Gore, John C et al. (2014) Proximal nerve magnetization transfer MRI relates to disability in Charcot-Marie-Tooth diseases. Neurology 83:1545-53
Brewer, Megan Hwa; Ma, Ki Hwan; Beecham, Gary W et al. (2014) Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2. Hum Mol Genet 23:5171-87
Lam, Byron L; Züchner, Stephan L; Dallman, Julia et al. (2014) Mutation K42E in dehydrodolichol diphosphate synthase (DHDDS) causes recessive retinitis pigmentosa. Adv Exp Med Biol 801:165-70
Finkel, Richard S; McDermott, Michael P; Kaufmann, Petra et al. (2014) Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology 83:810-7
Liu, Yo-Tsen; Laurá, Matilde; Hersheson, Joshua et al. (2014) Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy. Neurology 83:612-9
Mudge, Anita J; Bau, Karen V; Purcell, Leanne N et al. (2014) Normative reference values for lower limb joint range, bone torsion, and alignment in children aged 4-16 years. J Pediatr Orthop B 23:15-25
Foley, A Reghan; Menezes, Manoj P; Pandraud, Amelie et al. (2014) Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain 137:44-56
Ramchandren, Sindhu; Jaiswal, Mamta; Feldman, Eva et al. (2014) Effect of pain in pediatric inherited neuropathies. Neurology 82:793-7
Wen, Rong; Dallman, Julia E; Li, Yiwen et al. (2014) Knock-down DHDDS expression induces photoreceptor degeneration in zebrafish. Adv Exp Med Biol 801:543-50
Griffin, Laurie B; Sakaguchi, Reiko; McGuigan, David et al. (2014) Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Hum Mutat 35:1363-71

Showing the most recent 10 out of 53 publications